 | • レポートコード：MRC2303M129 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥665,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,225,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査資料によると、世界の人工肺装置市場規模が、予測期間中（2022年〜2027年）に年平均成長率5.4%で拡大すると予測されています。本書は、人工肺装置の世界市場にフォーカスし、最新動向と今後の市場性などをまとめており、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（気泡酸素発生器、膜型人工肺）分析、用途別（呼吸器、心臓、体外心肺蘇生法）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来の動向などが掲載されています。また、Chalice Medical Ltd、EUROSETS SRL、Getinge AB、Livanova PLC、Medtronic PLC、Microport Scientific Corporation、Nipro Medical Corporation、Terumo Medical Corporation、Braile Biomedica 、Xenios AG、MC3 Cardiopulmonary、Gen World Medical Devices、Senko Medical Instrument Mfg Co. Ltd (MERA)、Owgels Groupなど、主要企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の人工肺装置市場規模：製品別 - 気泡酸素発生器の市場規模 - 膜型人工肺の市場規模 ・世界の人工肺装置市場規模：用途別 - 呼吸器における市場規模 - 心臓における市場規模 - 体外心肺蘇生法における市場規模 ・世界の人工肺装置市場規模：地域別 - 北米の人工肺装置市場規模 アメリカの人工肺装置市場規模 カナダの人工肺装置市場規模 メキシコの人工肺装置市場規模 … - ヨーロッパの人工肺装置市場規模 イギリスの人工肺装置市場規模 フランスの人工肺装置市場規模 ドイツの人工肺装置市場規模 … - アジア太平洋の人工肺装置市場規模 中国の人工肺装置市場規模 インドの人工肺装置市場規模 日本の人工肺装置市場規模 … - 南米/中東の人工肺装置市場規模 ブラジルの人工肺装置市場規模 アルゼンチンの人工肺装置市場規模 南アフリカの人工肺装置市場規模 … - その他地域の人工肺装置市場規模 ・競争状況 ・市場機会・将来の動向 |
The oxygenators market is expected to register a CAGR of 5.4% during the forecast period 2022-2027.
To cope with the current COVID-19 situation, companies are increasing the production of oxygenators globally to support the adoption of ECMO procedures for the treatment of COVID-19 patients. There has been a huge increase in the demand for oxygenators in ICU units. In addition, these devices have the most significant aspects of critical care in surgical procedures and the management of COVID-19 patients; therefore, market players are launching products associated with oxygenators. COVID-19 also impacted the production of oxygenator products in 2020. Furthermore, the delay of elective procedures due to COVID-19-related measures adversely affected medical devices such as oxygenators, especially in the first half of 2020.
The major factors driving the growth of the market are the global prevalence of various coronary heart diseases and strokes due to changing lifestyles, leading to a rise in surgical interventions, favorable reimbursement initiatives, and rapid growth of the geriatric population. For instance, according to the World Health Organization, nearly 17.9 million people died from cardiovascular diseases in 2019, representing 32% of all global deaths, which directly resulted in higher demand for coronary artery bypass procedures, leading to a rising focus on oxygenators for efficient treatments, fueling the growth of the market throughout the forecast period.
Moreover, there is a rising burden of cardiovascular diseases across the world, and they are the leading causes of death. As per the 2020 statistics provided by the World Health Organization (WHO), ischemic heart disease is responsible for 16% of the world’s total deaths. As per the same source, an estimate of 8.9 million deaths were reported for ischemic heart disease in 2019. The rising prevalence of cardiovascular diseases is driving cardiopulmonary surgeries and coronary artery bypass grafting (CABG), which may increase the demand for oxygenators.
However, the adoption of minimally invasive procedures, like percutaneous coronary interventions, risks associated with oxygenation systems, and stringent US FDA regulations for Class II category devices, which should comply with the performance standards, are acting as barriers to the overall market growth.
Oxygenators Market Trends
The Membrane Oxygenators Segment is Expected to Hold the Largest Market Share
The membrane oxygenators segment is expected to witness the largest market share during the forecast period due to their rising adoption in CABG procedures and extracorporeal circulation for cardiopulmonary support in various surgical procedures, along with heart-lung machines, due to advantages such as reduction of the damage of tissues and thrombosis compared to bubble oxygenators. Also, their rapid deployability, effective gas exchange in a relatively small membrane surface area, enhanced blood flows, less hemolysis, and less post-operative bleeding further boost the growth of the segment.
Based on application, the respiratory segment is expected to hold a major market share during the forecast period. This can be attributed to the rise in the prevalence of chronic obstructive pulmonary disease (COPD) and cardiopulmonary diseases.
Moreover, in April 2020, an Indian firm, Genrich Membranes, which is being funded by the Department of Science and Technology (DST), India, developed membrane oxygenator equipment for the treatment of COVID-19 patients. Hence, companies are working on manufacturing oxygenators as the surgeries that were put on hold during the initial days are now resuming, and thus, the demand for these devices is rising.
North America is Expected to Dominate the Market Over the Forecast Period
The United States has been the most affected country across the world, as the non-emergent surgical procedures were put on hold, due to which the demand for these devices will decrease. However, the surgical procedures are resuming now with proper regulating guidelines, which will further increase the demand for these oxygenators, and the market growth will gradually rise.
North America is expected to dominate the overall oxygenators market throughout the forecast period. The major factors attributing to the growth are rise in the global prevalence of multiple cardiovascular indications like CAD, ischemic strokes, and atrial fibrillation, along with acute respiratory disorders such as acute respiratory distress syndrome (ARDS), due to a rise in chronic diseases, such as diabetes and obesity, necessitating the cardiopulmonary bypass procedures and thus, rise in demand for oxygenators. For instance, according to the Center for Disease Control and Prevention, 2021, heart disease accounts for one in four deaths in the United States. Coronary heart disease is the leading cause of deaths attributable to cardiovascular disease in the United States causing 360,900 deaths, followed by stroke (805,000). This scenario is leading to a higher demand for better treatment with efficient medication, which is driving the market in the United States.
Furthermore, favorable reimbursement policies, approvals by the Food and Drug Administration (FDA), and availability of healthcare infrastructure in the region are expected to fuel the market during the forecast period.
Oxygenators Market Competitor Analysis
The oxygenators market is moderately competitive and consists of several major players. Few of the key players are launching new products with advanced technologies to compete with the existing products, while others are acquiring and partnering with other companies trending in the market. Some of the companies currently dominating the market are Medtronic PLC, Terumo Medical Corporation, Getinge AB, EUROSETS SRL, and Livanova PLC.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Global Prevalence of Cardiopulmonary Disorders
4.2.2 Increasing Geriatric Population, Rise in Global Healthcare Expenditure, and Growth in Disposable Income
4.2.3 Availability of Technologically Advanced Products and Reimbursement Policies
4.3 Market Restraints
4.3.1 Adoption of Minimally Invasive Procedures and Risks Associated with Oxygenation Systems
4.3.2 Stringent FDA Regulations
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 Product Type
5.1.1 Bubble Oxygenator
5.1.2 Membrane Oxygenator
5.2 Application
5.2.1 Respiratory
5.2.2 Cardiac
5.2.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Chalice Medical Ltd
6.1.2 EUROSETS SRL
6.1.3 Getinge AB
6.1.4 Livanova PLC
6.1.5 Medtronic PLC
6.1.6 Microport Scientific Corporation
6.1.7 Nipro Medical Corporation
6.1.8 Terumo Medical Corporation
6.1.9 Braile Biomedica
6.1.10 Xenios AG
6.1.11 MC3 Cardiopulmonary
6.1.12 Gen World Medical Devices
6.1.13 Senko Medical Instrument Mfg Co. Ltd (MERA)
6.1.14 Owgels Group
7 MARKET OPPORTUNITIES AND FUTURE TRENDS